PLAZIER Trademark

Trademark Overview

On Monday, August 8, 2011, a trademark application was filed for PLAZIER with the United States Patent and Trademark Office. The USPTO has given the PLAZIER trademark a serial number of 85392201. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 9, 2015. This trademark is owned by Glaxo Group Limited. The PLAZIER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
plazier

General Information

Serial Number85392201
Word MarkPLAZIER
Filing DateMonday, August 8, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 9, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 11, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 9, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 9, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2014EXTENSION 5 GRANTED
Monday, June 23, 2014EXTENSION 5 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Saturday, February 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 7, 2014EXTENSION 4 GRANTED
Monday, January 27, 2014EXTENSION 4 FILED
Monday, January 27, 2014TEAS EXTENSION RECEIVED
Saturday, August 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2013EXTENSION 3 GRANTED
Tuesday, July 23, 2013EXTENSION 3 FILED
Tuesday, July 23, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 4, 2013EXTENSION 2 GRANTED
Monday, January 21, 2013EXTENSION 2 FILED
Monday, February 4, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 21, 2013TEAS EXTENSION RECEIVED
Friday, July 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 25, 2012EXTENSION 1 GRANTED
Wednesday, July 25, 2012EXTENSION 1 FILED
Wednesday, July 25, 2012TEAS EXTENSION RECEIVED
Tuesday, January 31, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 3, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 3, 2011ASSIGNED TO EXAMINER
Thursday, August 11, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 11, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

plazier pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological